Aethlon Medical (AEMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,267 | -3,249 | -1,762 | -13,388 | -7,133 |
| Depreciation Amortization | 463 | 308 | 155 | 340 | 465 |
| Other Working Capital | -662 | -577 | -180 | 94 | 352 |
| Other Operating Activity | 217 | 145 | 73 | 5,309 | 343 |
| Operating Cash Flow | $-5,248 | $-3,374 | $-1,715 | $-7,646 | $-5,973 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | N/A | N/A | N/A | -2 |
| Investing Cash Flow | $-2 | $N/A | $N/A | $N/A | $-2 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,750 | 3,745 | N/A | 7,911 | 5,384 |
| Other Financing Activity | -1,032 | -9 | -5 | -184 | -16 |
| Financing Cash Flow | $6,718 | $3,736 | $-5 | $7,727 | $5,368 |
| Exchange Rate Effect | -13 | -9 | -16 | -12 | -10 |
| Beginning Cash Position | 5,599 | 5,599 | 5,599 | 5,530 | 5,530 |
| End Cash Position | 7,055 | 5,952 | 3,863 | 5,599 | 4,913 |
| Net Cash Flow | $1,456 | $353 | $-1,736 | $70 | $-617 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,248 | -3,374 | -1,715 | -7,646 | -5,973 |
| Capital Expenditure | -2 | N/A | N/A | N/A | -2 |
| Free Cash Flow | -5,250 | -3,374 | -1,715 | -7,646 | -5,975 |